ArticlePancreas2019

Combined Antiangiogenic Therapy and Immunotherapy Is Effective for Pancreatic Cancer With Mismatch Repair Proficiency but High Tumor Mutation Burden: A Case Report.

Mengni Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.